Morgan Stanley’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$121K Sell
367,378
-551,510
-60% -$867K ﹤0.01% 6075
2025
Q4
$2.85M Buy
918,888
+352,469
+62% +$1.01M ﹤0.01% 4569
2025
Q3
$1.49M Sell
566,419
-252,272
-31% -$556K ﹤0.01% 4950
2025
Q2
$1.01M Buy
818,691
+359,158
+78% +$392K ﹤0.01% 5098
2025
Q1
$505K Buy
459,533
+310,978
+209% +$359K ﹤0.01% 5318
2024
Q4
$134K Sell
148,555
-31,680
-18% -$27.1K ﹤0.01% 5936
2024
Q3
$178K Sell
180,235
-14,429
-7% -$13.9K ﹤0.01% 5790
2024
Q2
$175K Sell
194,664
-4,140,436
-96% -$3.1M ﹤0.01% 5739
2024
Q1
$5.12M Sell
4,335,100
-6,802,644
-61% -$7.49M ﹤0.01% 3895
2023
Q4
$10.2M Buy
11,137,744
+10,746,373
+2,746% +$7.94M ﹤0.01% 3900
2023
Q3
$326K Sell
391,371
-184,889
-32% -$213K ﹤0.01% 5355
2023
Q2
$692K Sell
576,260
-193,550
-25% -$241K ﹤0.01% 5044
2023
Q1
$970K Sell
769,810
-2,393,535
-76% -$4.58M ﹤0.01% 4880
2022
Q4
$6.86M Buy
3,163,345
+1,955,742
+162% +$16.1M ﹤0.01% 3458
2022
Q3
$14.5M Sell
1,207,603
-169,661
-12% -$2.11M ﹤0.01% 2564
2022
Q2
$11.5M Buy
1,377,264
+84,709
+7% +$656K ﹤0.01% 2924
2022
Q1
$11.2M Buy
1,292,555
+70,700
+6% +$682K ﹤0.01% 2785
2021
Q4
$13.8M Buy
1,221,855
+967,952
+381% +$11.5M ﹤0.01% 2562
2021
Q3
$3.19M Sell
253,903
-54,842
-18% -$505K ﹤0.01% 4163
2021
Q2
$2.51M Sell
308,745
-20,216
-6% -$175K ﹤0.01% 4462
2021
Q1
$3.04M Sell
328,961
-18,243
-5% -$184K ﹤0.01% 3911
2020
Q4
$3.36M Buy
347,204
+148,418
+75% +$1.46M ﹤0.01% 3693
2020
Q3
$2.47M Sell
198,786
-180,065
-48% -$2.39M ﹤0.01% 3462
2020
Q2
$4.92M Buy
378,851
+186,713
+97% +$2.35M ﹤0.01% 2689
2020
Q1
$1.95M Buy
192,138
+106,427
+124% +$1.39M ﹤0.01% 3391
2019
Q4
$1.34M Sell
85,711
-30,307
-26% -$610K ﹤0.01% 4332
2019
Q3
$1.95M Buy
116,018
+114,921
+10,476% +$2.29M ﹤0.01% 3817
2019
Q2
$24K Sell
1,097
-1,005
-48% -$19.2K ﹤0.01% 5872
2019
Q1
$46K Buy
+2,102
New +$43.8K ﹤0.01% 5707

Other funds holding GOSS